Seeking Alpha

Leerink Swann says the pricing for Corcept's (CORT -0.8%) Korlym is higher than expected at $186...

Leerink Swann says the pricing for Corcept's (CORT -0.8%) Korlym is higher than expected at $186 per 300mg tablet, which should help offset its caution regarding patient numbers. The drug developer announced this morning it will begin shipping Korlym starting April 11.
From other sites
Comments (1)
  • Donald Blum
    , contributor
    Comments (96) | Send Message
     
    Any numbers on how many patients, and how often, they will take this medication?
    22 Mar 2012, 01:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector